Código QR (código de barras bidimensional)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies

The age-related macular degeneration (AMD) field is witnessing promising advancements in therapeutic options. Breakthrough drugs such as pegcetacoplan and avacincaptad have been FDA-approved for dry AMD, marking a significant development as there were no treatment options until August 2023. While se...

ver descrição completa

Na minha lista:
Principais autores: Audrey Yan, Nasiq Hasan, Jay Chhablani
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2025-01-01
coleção:Indian Journal of Ophthalmology
Assuntos:
age-related macular degeneration
anti-vegf inhibitors
dry amd
gene therapy
upcoming amd therapy
wet amd
Acesso em linha:https://journals.lww.com/10.4103/IJO.IJO_1120_24
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados